CEACAM5 and colorectal adenocarcinoma: T84.66 is a well-characterized anti-CEA murine IgG1 monoclonal antibody (mAb) that does not cross-react with other members of the CEA gene family and has successfully been used for 111In imaging of patients with primary colorectal adenocarcinomas (22, 23).